|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Assets: | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Deferred offering costs | |||||
| Total current assets | |||||
| Prepaid expenses, non-current | |||||
| Marketable securities held in Trust Account | |||||
| Total Assets | |||||
| Liabilities and Shareholders’ (Deficit) Equity | |||||
| Accrued offering costs and expenses | |||||
| Promissory note – related party | |||||
| Related party loan | |||||
| Working Capital Loans | |||||
| Due to related party | |||||
| Total current liabilities | |||||
| Deferred underwriting commissions | |||||
| Total Liabilities | |||||
| Ordinary shares subject to possible redemption, 11,500,000 and 0 shares at September 30, 2022 and September 30, 2021, respectively | |||||
| Shareholders’ (Deficit) Equity | |||||
| Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 3,075,000 shares issued and outstanding (excluding 11,500,000 and 0 shares subject to possible redemption) at September 30, 2022 and September 30, 2021, respectively | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ (Deficit) Equity | |||||
| Total Liabilities and Shareholders’ (Deficit) Equity |
Loading...
